Applying the neoadjuvant paradigm to ductal carcinoma in situ.

Annals of surgical oncology : the official journal of the Society of Surgical Oncology

Volumn 11, Issue 1 Suppl, 2004, Pages

  Esserman, Laura ^a   Sepucha, Karen ^a   Ozanne, Elissa ^a   Hwang, E Shelley ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN SYNTHASE INHIBITOR;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; DECISION SUPPORT SYSTEM; DISEASE COURSE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; RISK ASSESSMENT; SEGMENTAL MASTECTOMY; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; CYCLOOXYGENASE INHIBITORS; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

MLCS; MLOWN;

EID: 2142829470     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02524793     Document Type: Article

References (0)